Fig. 4
A diagram representing the timeline for the development of therapeutics employed in endometriosis treatment. This figure shows a timely development of the conventional agents for endometriosis in a progressive manner. The conventional agents comprise Anti-androgens (Danazol), Progestins (Norethindrone acetate, Medroxyprogesterone acetate), GnRH antagonists (Elagolix), GnRH agonists (Gosrelin, Leuprolide, Nafrelin). The year of authorization along with their mechanisms in endometriosis has been provided in the above figure